FDA 483 - Etex Corporation - May 23, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Etex Corporation in Braintree, MA, a human tissue firm and device manufacturer, revealed a significant issue regarding the documentation accompanying Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Specifically, the firm's EquivaBone product was distributed without the required Summary of Records Report for donor-eligibility determination. Additionally, the product's Instruction for Use (IFU) failed to include a complete listing and interpretation of communicable disease test results and the name and address of the establishment that made the donor-eligibility determination.
ID · 1b0d65ae-6414-48d4-be19-9379eb6e69f7